LARIMAR THERAPEUTICS, INC.: cashflow_financing

Value{"amount": 108115000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2026-01-01 – 2026-03-31
Statuscurrent
EntityLARIMAR THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-26-224087 · Open the official SEC filing →
Retrieved: 2026-08-19T13:12:19.292167+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001374690/cashflow-financing/2026-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/e31cb94d-a653-47e2-ba87-cad4d6d622e1

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies